Changes in Renal Function and Body Composition in Pulmonary Hypertension
Prospective Evaluation of Changes in Renal Function and Body Composition in Patients With Pulmonary Hypertension
1 other identifier
observational
500
1 country
1
Brief Summary
Changes in renal function and body composition in patients with pulmonary hypertension
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 25, 2017
CompletedFirst Submitted
Initial submission to the registry
January 29, 2017
CompletedFirst Posted
Study publicly available on registry
February 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 9, 2020
CompletedDecember 17, 2020
December 1, 2020
2.7 years
January 29, 2017
December 14, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in renal function in patients with pulmonary hypertension
Estimated GFR based on Chronic Kidney Disease Epidemiology Collaboration-creatinine-cystatin C will be used to determine renal function at baseline and at 1 year follow-up
1 year
Secondary Outcomes (3)
Changes in hydration status in patients with pulmonary hypertension
1 year
Changes in nutritional status in patients with pulmonary hypertension
1 year
Prognostic value of baseline renal function, hydration and nutritional status on pulmonary hypertension-associated morbidity and mortality
1 year
Study Arms (1)
Pulmonary Hypertension
Adult outpatients with suspected or prediagnosed pulmonary hypertension irrespective of subclass and all chronic kidney disease stages
Interventions
Eligibility Criteria
All patients with suspected or pre-diagnosed pulmonary hypertension at pulmonary hypertension outpatient clinic, University Hospital Giessen and Marburg, Campus Giessen
You may qualify if:
- Subjects older than 18 years at pulmonary hypertension outpatient clinic
- Subjects who signed informed consent forms
You may not qualify if:
- Patients refusing to participate or withdraw consent during follow-up
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Clinic Giessen and Marburg - Campus Giessen
Giessen, Hesse, 35392, Germany
Related Publications (4)
Bellomo R, Prowle JR, Echeverri JE. Diuretic therapy in fluid-overloaded and heart failure patients. Contrib Nephrol. 2010;164:153-163. doi: 10.1159/000313728. Epub 2010 Apr 20.
PMID: 20428001BACKGROUNDRonco C, Verger C, Crepaldi C, Pham J, De Los Rios T, Gauly A, Wabel P, Van Biesen W; IPOD-PD Study Group. Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)dagger. Nephrol Dial Transplant. 2015 May;30(5):849-58. doi: 10.1093/ndt/gfv013. Epub 2015 Mar 11.
PMID: 25762355BACKGROUNDNavaneethan SD, Wehbe E, Heresi GA, Gaur V, Minai OA, Arrigain S, Nally JV Jr, Schold JD, Rahman M, Dweik RA. Presence and outcomes of kidney disease in patients with pulmonary hypertension. Clin J Am Soc Nephrol. 2014 May;9(5):855-63. doi: 10.2215/CJN.10191013. Epub 2014 Feb 27.
PMID: 24578332RESULTDamman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009 Feb 17;53(7):582-588. doi: 10.1016/j.jacc.2008.08.080.
PMID: 19215832RESULT
Biospecimen
Collection of only residual material (blood, urine) for Deutsche Zentrum für Lungenforschung Biobank.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Werner Seeger, MD
Department of Internal Medicine II, Division of Pulmonology, Nephrology and Critical Care Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Physician Nephrology
Study Record Dates
First Submitted
January 29, 2017
First Posted
February 1, 2017
Study Start
January 25, 2017
Primary Completion
October 7, 2019
Study Completion
July 9, 2020
Last Updated
December 17, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Starting 6 months after publication
All IPD that underlie results in a publication